Evidence map›Paper›PMID 37725767›Full record

ArticleJCO global oncology2023

Feasibility and Clinical Acceptability of Automation-Assisted 3D Conformal Radiotherapy Planning for Patients With Cervical Cancer in a Resource-Constrained Setting.

Sikudhani Muya, Jerry Ndumbalo, Sarah Kutika Nyagabona, Shaid Yusuf, Dong Joo Rhee, Beatrice Paul Mushi, Benjamin Li, Li Zhang, Surbhi Grover, Mary Feng and 5 more

Open access · goldAbstract read
In one paragraph

Article in JCO global oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Sikudhani MuyaMuhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.ORCID 0000-0001-6634-4277
Jerry NdumbaloMuhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.ORCID 0000-0002-4853-5499
Sarah Kutika NyagabonaMuhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.ORCID 0000-0002-1295-3197
Shaid YusufMuhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Dong Joo RheeMD Anderson Cancer Center, Houston, TX.ORCID 0000-0003-0486-1556
Beatrice Paul MushiMuhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.ORCID 0000-0002-5700-8017
Benjamin LiUniversity of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.ORCID 0000-0002-1783-7013
Li ZhangUniversity of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.
Surbhi GroverUniversity of Pennsylvania, Philadelphia, PA.ORCID 0000-0001-7443-5937
Mary FengUniversity of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.
I-Chow HsuUniversity of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.ORCID 0000-0002-3113-121X
Elia MmbagaMuhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.ORCID 0000-0003-3768-0225
Katherine Van LoonUniversity of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.ORCID 0000-0002-9705-4114
Laurence CourtMD Anderson Cancer Center, Houston, TX.ORCID 0000-0002-3241-6145
Melody XuUniversity of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.ORCID 0000-0001-5459-5730
Muhimbili University of Health and Allied Sciences · TZUniversity of California, San Francisco · USThe University of Texas MD Anderson Cancer Center · USUniversity of Pennsylvania · US

Funding

Prognostic value of quantitative HPV viral load in determining cervical cancer treatment response and recurrenceK08CA230170 · NCI · UNIVERSITY OF PENNSYLVANIA · PI GROVER, SURBHI · 2019 to 2023
$1.4M
NCI NIH HHS K08 CA230170
6 · The paper itself

Abstract

purposeThe Ocean Road Cancer Institute (ORCI) in Tanzania began offering 3D conformal radiation therapy (3DCRT) in 2018. Steep learning curves, high patient volume, and a limited workforce resulted in long radiation therapy (RT) planning workflows. We aimed to establish the feasibility of implementing an automation-assisted cervical cancer 3DCRT planning system. MATERIALS AND

methodsWe performed chart abstractions on 30 patients with cervical cancer treated with 3DCRT at ORCI. The Radiation Planning Assistant (RPA) generated a new automated set of contours and plans on the basis of anonymized computed tomography images. Each were assessed for edit time requirements, dose-volume safety metrics, and clinical acceptability by two ORCI physician investigators. Dice similarity coefficient (DSC) agreement analysis was conducted between original and new contour sets.

resultsThe average time to manually develop treatment plans was 7 days. Applying RPA, automated same-day contours and plans were developed for 29 of 30 patients (97%). Of the 29 evaluable contours, all were approved with <2 minutes of edit time. Agreement between clinical and RPA contours was highest for the rectum (median DSC, 0.72) and bladder (DSC, 0.90). Agreement was lower with the primary tumor clinical target volume (CTVp; DSC, 0.69) and elective nodal clinical target volume (CTVn; DSC, 0.63). All RPA plans were approved with <4 minutes of edit time. RPA target coverage was excellent, covering the CTVp with median V45 Gy 100% and CTVn with median V45 Gy 99.9%.

conclusionAutomation-assisted 3DCRT contouring yielded high levels of agreement for normal structures. The RPA met all planning safety metrics and sustained high levels of clinical acceptability with minimal edit times. This tool offers the potential to significantly decrease RT planning timelines while maintaining high-quality RT delivery in resource-constrained settings.

Indexed as

Radiotherapy, ConformalUterine Cervical NeoplasmsAcademies and InstitutesAutomationFeasibility StudiesFemaleHumans

Identifiers

PMID37725767
PMCPMC10581615
OpenAlexW4386865881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.